Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression

Leukemia

Volumn 11, Issue 2, 1997, Pages 190-194

  Ohyashiki, K ^a   Ohyashiki, J H ^a   Iwama, H ^a   Hayashi, S ^a   Shay, J W ^b   Toyama, K ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Blast crisis; Chronic myeloid leukemia; Telomerase activity; Telomere

Indexed keywords

TELOMERASE;

ARTICLE; BLOOD CELL; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; HUMAN; HUMAN CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RESTRICTION FRAGMENT; TELOMERE; TUMOR CELL;

EID: 0031050032     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400560     Document Type: Article

References (29)

1. Zakian VA. Structure and function of telomeres. Annu Rev Genet 1989; 32: 579-604.
2. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-573.
3. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990; 345: 458-460.
4. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992; 225: 951-960.
5. Blackburn EH. Telomerases. Annu Rev Biochem 1982; 61: 113-129.
6. de Lange T. Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 1994; 91: 2882-2885.
7. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43: 405-413.
8. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521-529.
9. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991; 256: 271-282.
10. Shay JW, Werbin H, Wright WE. Telomere shortening may contribute to aging and cancer. A perspective. Mol Cell Diff 1994; 2: 1-21.
11. Shay JW. Ageing and cancer: are telomeres and telomerase the connection? Mol Med Today 1995; 1: 378-384.
12. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with aging. Nature 1990; 346: 866-868.
13. Hiyama E, Hiyama K, Yokoyama T, Ichikawa T, Matsuura Y. Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn J Cancer Res 1992; 83: 159-164.
14. de Lange T. Telomere dynamics and genome instability in human cancer. In: Blackburn EH, Greider CW (eds). Telomeres. Cold Spring Harbor Laboratory Press: Plainview, NY, 1994, pp 265-293.
15. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11: 1921-1929.
16. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994; 68: 3410-3414.
17. Ohyashiki JH et al. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 1994; 54: 3557-3560.
18. Yamada O, Oshimi K, Motoji T, Mizoguchi H. Telomeric DNA in normal and leukemic blood cells. J Clin Invest 1995; 93: 1117-1123.
19. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85: 2315-2320.
20. Nilsson P, Mehle C, Remes K, Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994; 9: 3043-3048.
21. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
22. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE, Shay JW. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Meth Cell Sci 1995; 17: 1-15.
23. Ohyashiki JH, Ohyashiki K, Toyama K, Shay JW. A non-radioactive fluorescence-based telomeric repeat amplification protocol to detect and quantitate telomerase activity. Trends Genet 1996; 12: 395-396.
24. Ohyashiki JH, Ohyashiki K, Sano T, Toyama K. Non-radioisotopic and semiquantitative procedure for telomeric repeat amplification protocol. Jpn J Cancer Res 1996; 87: 329-331.
25. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acid Res 1995; 23: 3794-3795.
26. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW, Piatyszek MA, Wright WE, Shay JW. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994; 59: 307-315.
27. Hiyama K, Hirai Y, Koizumi S, Akiyama M, Hiyama E, Piatyszek A, Shay-JW, Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-3715.
28. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92: 9082-9086.
29. Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW, Toyama K. Telomerase reactivation in leukemia cells. Int J Oncol 1996; 8: 417-421.